Alpha-1-acid glycoprotein (A1AG) and Xaa Pro dipeptidase (PEPD) were reported to be a potential biomarker in HCC patients in serum samples (Ahn et al., 2012; Ilikhan et al., 2015). This evidence concerns the gene ORM1 and hepatocellular carcinoma.